MNMD
Income statement / Annual
Last year (2023), Mind Medicine (MindMed) Inc.'s total revenue was $0.00,
and the percentage change from the previous year is not available.
In 2023, Mind Medicine (MindMed) Inc.'s net income was -$95.73 M.
See Mind Medicine (MindMed) Inc.’s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
| Period Ended |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
08/31/2019 |
08/31/2018 |
08/31/2017 |
08/31/2016 |
08/31/2015 |
| Operating Revenue |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Cost of Revenue |
$3.16 M |
$3.22 M |
$2.62 M |
$0.00 |
$6,683.69 |
$6,681.56 |
$5,500.92 |
$0.00 |
$0.00 |
| Gross Profit |
-$3.16 M |
-$3.22 M |
-$2.62 M |
$0.00 |
-$6,683.69 |
-$6,681.56 |
-$5,500.92 |
$0.00 |
$0.00 |
| Gross Profit Ratio |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
| Research and Development
Expenses |
$48.96 M
|
$36.17 M
|
$34.79 M
|
$18.63 M
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| General & Administrative
Expenses |
$41.74 M
|
$30.16 M
|
$59.07 M
|
$14.40 M
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling & Marketing
Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General &
Administrative Expenses |
$41.74 M
|
$30.16 M
|
$59.07 M
|
$14.40 M
|
$461,501.00
|
$855,262.00
|
$1.23 M
|
$111,252.00
|
$94,553.00
|
| Other Expenses |
$0.00 |
$2,000.00 |
$106,000.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
| Operating Expenses |
$93.87 M |
$66.33 M |
$93.85 M |
$33.03 M |
$461,501.00 |
$855,262.00 |
$1.23 M |
$111,252.00 |
$94,553.00 |
| Cost And Expenses |
$93.87 M |
$66.33 M |
$93.85 M |
$33.03 M |
$468,184.00 |
$861,944.00 |
$1.24 M |
$111,252.00 |
$94,553.00 |
| Interest Income |
$4.66 M |
$1.50 M |
$0.00 |
$0.00 |
$0.00 |
$4,000.17 |
$8,396.41 |
$1,200.02 |
$1,897.53 |
| Interest Expense |
$0.00 |
$1.50 M |
$359,000.00 |
$164,000.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
| Depreciation &
Amortization |
$3.16 M
|
$3.22 M
|
$2.62 M
|
$206,297.00
|
$6,683.69
|
$6,681.56
|
$5,500.92
|
$0.00
|
$0.39
|
| EBITDA |
-$92.57 M
|
-$53.57 M
|
-$91.22 M
|
-$33.77 M
|
-$1.11 M
|
-$851,262.00
|
-$1.51 M
|
-$111,250.00
|
-$92,656.00
|
| EBITDA Ratio |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
| Operating Income Ratio
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
| Total Other
Income/Expenses Net |
-$1.87 M
|
$9.54 M
|
-$339,000.00
|
-$907,000.00
|
-$647,626.00
|
$3,996.00
|
$8,397.00
|
-$68,650.00
|
$1,894.00
|
| Income Before Tax |
-$95.73 M |
-$56.80 M |
-$94.19 M |
-$33.94 M |
-$1.12 M |
-$857,944.00 |
-$1.23 M |
-$179,900.00 |
-$92,656.00 |
| Income Before Tax Ratio
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
| Income Tax Expense |
$0.00 |
-$9.54 M |
-$1.16 M |
$164,000.00 |
-$3.69 |
-$1.91 |
-$1.70 |
$0.00 |
-$0.39 |
| Net Income |
-$95.73 M |
-$47.26 M |
-$93.04 M |
-$34.10 M |
-$1.12 M |
-$857,944.00 |
-$1.23 M |
-$179,900.00 |
-$92,656.00 |
| Net Income Ratio |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
| EPS |
-2.44 |
-1.53 |
-3.4 |
-1.92 |
-2.94 |
-2.74 |
-4.85 |
-2.24 |
-1.17 |
| EPS Diluted |
-2.44 |
-1.53 |
-3.4 |
-1.92 |
-2.94 |
-2.74 |
-4.85 |
-2.24 |
-1.17 |
| Weighted Average Shares
Out |
$39.16 M
|
$30.86 M
|
$27.38 M
|
$17.75 M
|
$379,411.00
|
$312,548.00
|
$252,818.00
|
$80,416.00
|
$79,001.00
|
| Weighted Average Shares
Out Diluted |
$39.16 M
|
$30.86 M
|
$27.38 M
|
$17.75 M
|
$379,411.00
|
$312,548.00
|
$252,818.00
|
$80,416.00
|
$79,001.00
|
| Link |
|
|
|
|
|
|
|
|
|
